Double Medical Technology Inc.

SZSE:002901 Stock Report

Market Cap: CN¥14.3b

Double Medical Technology Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Jiong Luo

Chief executive officer

CN¥1.5m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.06%
Management average tenure9.2yrs
Board average tenure6yrs

Recent management updates

Recent updates

Double Medical Technology Inc. (SZSE:002901) Not Lagging Industry On Growth Or Pricing

Jan 08
Double Medical Technology Inc. (SZSE:002901) Not Lagging Industry On Growth Or Pricing

There Are Reasons To Feel Uneasy About Double Medical Technology's (SZSE:002901) Returns On Capital

Dec 18
There Are Reasons To Feel Uneasy About Double Medical Technology's (SZSE:002901) Returns On Capital

Market Participants Recognise Double Medical Technology Inc.'s (SZSE:002901) Revenues Pushing Shares 29% Higher

Oct 01
Market Participants Recognise Double Medical Technology Inc.'s (SZSE:002901) Revenues Pushing Shares 29% Higher

Is Double Medical Technology (SZSE:002901) A Risky Investment?

Sep 27
Is Double Medical Technology (SZSE:002901) A Risky Investment?

Capital Allocation Trends At Double Medical Technology (SZSE:002901) Aren't Ideal

Sep 05
Capital Allocation Trends At Double Medical Technology (SZSE:002901) Aren't Ideal

Double Medical Technology (SZSE:002901) Seems To Use Debt Quite Sensibly

Jun 19
Double Medical Technology (SZSE:002901) Seems To Use Debt Quite Sensibly

Investors Could Be Concerned With Double Medical Technology's (SZSE:002901) Returns On Capital

May 28
Investors Could Be Concerned With Double Medical Technology's (SZSE:002901) Returns On Capital

CEO

Jiong Luo (56 yo)

no data

Tenure

CN¥1,456,800

Compensation

Mr. Jiong Luo serves as General Manager and Director of Double Medical Technology Inc. Mr. Luo served as General Manager of China Region of Xin Di Si (Shanghai) Medical Device Trading Company Limited from...


Leadership Team

NamePositionTenureCompensationOwnership
Jiong Luo
GM & Directorno dataCN¥1.46m0.064%
CN¥ 9.1m
Dong Ruan
Administrative Director9.2yrsCN¥525.90k0.0056%
CN¥ 797.9k
Shao Han
R & D Director9.2yrsCN¥672.10k0.0049%
CN¥ 706.2k
Danhe Chen
Financial Director & Accounting Supervisor1.4yrsno datano data
Xiannan Hua
Board Secretaryno datano datano data

9.2yrs

Average Tenure

47.5yo

Average Age

Experienced Management: 002901's management team is seasoned and experienced (9.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jiong Luo
GM & Directorno dataCN¥1.46m0.064%
CN¥ 9.1m
Zhi Xiong Lin
Chairman of Board of Directorsno dataCN¥508.80k85.09%
CN¥ 12.2b
Zhi Lin
Vice Chairmanno dataCN¥491.00kno data
Xiao Lin
Director9.2yrsno datano data
Huanhuan Zhan
Chairman of Supervisory Boardno datano data0.0018%
CN¥ 263.6k
Ming Zhang
Member of Supervisory Board9.3yrsno datano data
Qi Wu
Employee Representative Member of Supervisory Boardno datano datano data
Yanyan Wang
Independent Director6yrsCN¥80.00kno data
Lin Lin
Independent Director6yrsCN¥80.00kno data
Wei Xiao
Independent Director2.3yrsCN¥80.00kno data

6.0yrs

Average Tenure

49.5yo

Average Age

Experienced Board: 002901's board of directors are considered experienced (6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 02:30
End of Day Share Price 2025/01/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Double Medical Technology Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhu ChenCitic Securities Co., Ltd.
Shuo SongCitic Securities Co., Ltd.
Song YangTianfeng Securities Brokerage Co., Ltd